LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation - PubMed (original) (raw)
. 2007 Feb 16;282(7):4310-4317.
doi: 10.1074/jbc.M610826200. Epub 2006 Dec 13.
Affiliations
- PMID: 17166850
- DOI: 10.1074/jbc.M610826200
Free article
LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation
Chang-Wook Lee et al. J Biol Chem. 2007.
Free article
Abstract
Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that signals through G protein-coupled receptors (GPCRs) to produce a range of biological responses. A recently reported fourth receptor, LPA(4)/GPR23, was notable for its low homology to the previously identified receptors LPA(1-3) and for its ability to increase intracellular concentrations of cAMP and calcium. However, the signaling pathways leading to LPA(4)-mediated induction of cAMP and calcium levels have not been reported. Using epitope-tagged LPA(4), pharmacological intervention, and G protein mini-genes, we provide independent confirmatory evidence that supports LPA(4) as a fourth LPA receptor, including LPA concentration-dependent responses and specific membrane binding. Importantly, we further demonstrate new LPA-dependent activities of LPA(4) that include the following: receptor internalization; G(12/13)- and Rho-mediated neurite retraction and stress fiber formation; G(q) protein and pertussis toxin-sensitive calcium mobilization and activation of a nonselective cation conductance; and cAMP increases mediated by G(s). The receptor is broadly expressed in embryonic tissues, including brain, as determined by Northern blot and reverse transcription-PCR analysis. Adult tissues have increased expression in skin, heart, and to a lesser extent, thymus. These data confirm the identification and extend the functionality of LPA(4) as an LPA receptor, bringing the number of independently verified LPA receptors to five, with both overlapping and distinct signaling properties and tissue expression.
Similar articles
- LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.
Yanagida K, Ishii S, Hamano F, Noguchi K, Shimizu T. Yanagida K, et al. J Biol Chem. 2007 Feb 23;282(8):5814-24. doi: 10.1074/jbc.M610767200. Epub 2006 Dec 17. J Biol Chem. 2007. PMID: 17172642 - P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.
Lee M, Choi S, Halldén G, Yo SJ, Schichnes D, Aponte GW. Lee M, et al. Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G641-54. doi: 10.1152/ajpgi.00191.2009. Epub 2009 Aug 13. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19679818 Free PMC article. - GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.
Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. Lee CW, et al. J Biol Chem. 2006 Aug 18;281(33):23589-97. doi: 10.1074/jbc.M603670200. Epub 2006 Jun 14. J Biol Chem. 2006. PMID: 16774927 - Non-Edg family lysophosphatidic acid (LPA) receptors.
Ishii S, Noguchi K, Yanagida K. Ishii S, et al. Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):57-65. doi: 10.1016/j.prostaglandins.2009.06.001. Epub 2009 Jun 12. Prostaglandins Other Lipid Mediat. 2009. PMID: 19524700 Review. - LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
Hama K, Aoki J. Hama K, et al. Prog Lipid Res. 2010 Oct;49(4):335-42. doi: 10.1016/j.plipres.2010.03.001. Epub 2010 Mar 15. Prog Lipid Res. 2010. PMID: 20230855 Review.
Cited by
- Autotaxin Implication in Cancer Metastasis and Autoimunne Disorders: Functional Implication of Binding Autotaxin to the Cell Surface.
Peyruchaud O, Saier L, Leblanc R. Peyruchaud O, et al. Cancers (Basel). 2019 Dec 31;12(1):105. doi: 10.3390/cancers12010105. Cancers (Basel). 2019. PMID: 31906151 Free PMC article. Review. - Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases.
Jiang S, Yang H, Li M. Jiang S, et al. Int J Mol Sci. 2023 Aug 7;24(15):12524. doi: 10.3390/ijms241512524. Int J Mol Sci. 2023. PMID: 37569902 Free PMC article. Review. - International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.
Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. Chun J, et al. Pharmacol Rev. 2010 Dec;62(4):579-87. doi: 10.1124/pr.110.003111. Pharmacol Rev. 2010. PMID: 21079037 Free PMC article. Review. - Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
Valdés-Rives SA, González-Arenas A. Valdés-Rives SA, et al. Mediators Inflamm. 2017;2017:9173090. doi: 10.1155/2017/9173090. Epub 2017 Dec 21. Mediators Inflamm. 2017. PMID: 29430083 Free PMC article. Review. - Comparative analyses of lysophosphatidic acid receptor-mediated signaling.
Fukushima N, Ishii S, Tsujiuchi T, Kagawa N, Katoh K. Fukushima N, et al. Cell Mol Life Sci. 2015 Jun;72(12):2377-94. doi: 10.1007/s00018-015-1872-8. Epub 2015 Mar 4. Cell Mol Life Sci. 2015. PMID: 25732591 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous